SCHEMBL10356551

SCHEMBL10356551

CCOC(=O)CCCN1CCc2cc(NS(=O)(=O)c3ccccc3)ccc2C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR7 P34969 4/20 0.48
▸ ABCB1 P08183 1/20 0.48
▸ DRD2 P14416 5/20 0.47
▸ DRD3 P35462 5/20 0.47
▸ HTR6 P50406 4/20 0.47
▸ HTR2A P28223 3/20 0.47
▸ HTR2C P28335 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ KCNA1 Q09470 2/20 0.47
▸ KCNAB1 Q14722 2/20 0.47
▸ MLNR O43193 3/20 0.46
▸ HTR1A P08908 1/20 0.43
▸ SLC6A4 P31645 1/20 0.43
▸ HRH1 P35367 1/20 0.43
▸ HTR2B P41595 1/20 0.43
▸ GHSR Q92847 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10356496 0.94 DRD2 (0.49) HTR7ABCB1DRD2DRD3HTR6
SCHEMBL10563209 0.87 HTR7 (0.55) HTR7ABCB1DRD2DRD3HTR6
SCHEMBL10356972 0.82 MOGAT2 (0.49) HTR7DRD2DRD3HTR6HTR2A
SCHEMBL10357471 0.81 PRMT5 (0.48) DRD2DRD3HTR6HTR2AHTR2C
SCHEMBL10356555 0.81 CARM1 (0.58) HTR7DRD2DRD3HTR6HTR2A
SCHEMBL10357280 0.81 HTR7 (0.55) HTR7ABCB1DRD2DRD3HTR6
SCHEMBL10356557 0.79 CARM1 (0.57) HTR7HTR6
Hydrochloric Acid SCHEMBL10564508 0.78 PRMT5 (0.47) HTR7DRD2DRD3MLNR
SCHEMBL8054281 0.76 HTR7 (0.57) HTR7ABCB1DRD2DRD3HTR6
SCHEMBL10356540 0.76 PRMT5 (0.52) DRD2DRD3HTR6HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0266949-B1 TETRAHYDROISOQUINOLIN-2-YL DERIVATIVES OF CARBOXYLIC ACIDS AS THROMBOXANE A2 ANTAGONISTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1990-11-28 — — EP disclosed
US-4812573-A ARYLSULFONAMIDE SUBSTITUTED TETRAHYDROISOQUINOLINYLALKANOIC ACIDS AS THROMBOXANE A2 ANTAGONISTS SMITHKLINE & FRENCH LABORATORIES, LTD. (GB) 1989-03-14 — — US disclosed
EP-0266949-A1 Tetrahydroisoquinolin-2-yl derivatives of carboxylic acids as thromboxane A2 antagonists SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1988-05-11 — — EP disclosed
WO-1988003137-A1 TETRAHYDROISOQUINOLIN-2-YL DERIVATIVES OF CARBOXYLIC ACIDS AS THROMBOXANE A2 ANTAGONISTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1988-05-05 — — WO disclosed
Send feedback